Custom Cardiology Panel


  • Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
  • Cutis Laxa
  • Danon Disease
  • Dilated Cardiomyopathy (DCM)
  • Ehlers-Danlos Syndrome
  • Fabry Disease
  • Familial Hypercholesterolemia
  • Homocystinuria due to Cystathionine Beta-Synthase Deficiency
  • Hypertrophic Cardiomyopathy (HCM)
  • Left Ventricular Noncompaction (LVNC)
  • Loeys-Dietz syndrome (LDS)
  • Long QT Syndrome (LQTS)
  • Marfan Syndrome/LDS/Related Disorders
  • Multiple Epiphyseal Dysplasia (MED)
  • Noonan Syndrome
  • Occipital Horn Disease
  • Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
  • Arterial Tortuosity syndrome
  • Short QT Syndrome (SQTS)
  • Stickler syndrome
  • Sudden Cardiac Arrest
  • Sudden Unexplained Death
  • Thoracic Aortic Aneurysm and Dissection (TAAD) and Related Disorders
  • Transthyretin Amyloidosis
  • Wolff-Parkinson-White Syndrome
  • Non-ocular stickler (STL3) / otospondylomegaepiphyseal dysplasia (OSMED)/ DFNA13/ DFNB53
  • Brittle Cornea syndrome
  • Brugada Syndrome
  • Fibrochondrogenesis
  • Marshall syndrome
  • Spondyloepiphyseal dysplasia spectrum disorders
  • Weissenbach-Zweymuller syndrome

Clinical Utility

  • Confirmation of clinical diagnosis in symptomatic patients
  • Genetic counseling and risk assessment of asymptomatic family members of a proband with a hereditary cardiovascular condition

Lab Method

  • Next-Gen Sequencing
  • Deletion/Duplication Analysis

Important Information

Customizable Cardiology Panel

Test Code


CPT Codes*

Varies by gene

ABN Required


Turnaround Time**

4 weeks

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.